OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Newborn screening for spinal muscular atrophy in Australia: a non-randomised cohort study
Didu Kariyawasam, Arlene D’Silva, Hugo Sampaio, et al.
The Lancet Child & Adolescent Health (2023) Vol. 7, Iss. 3, pp. 159-170
Closed Access | Times Cited: 45
Didu Kariyawasam, Arlene D’Silva, Hugo Sampaio, et al.
The Lancet Child & Adolescent Health (2023) Vol. 7, Iss. 3, pp. 159-170
Closed Access | Times Cited: 45
Showing 1-25 of 45 citing articles:
Genomic newborn screening for rare diseases
Zornitza Stark, Richard H. Scott
Nature Reviews Genetics (2023) Vol. 24, Iss. 11, pp. 755-766
Closed Access | Times Cited: 98
Zornitza Stark, Richard H. Scott
Nature Reviews Genetics (2023) Vol. 24, Iss. 11, pp. 755-766
Closed Access | Times Cited: 98
Spinal Muscular Atrophy: The Past, Present, and Future of Diagnosis and Treatment
Hisahide Nishio, Emma Tabe Eko Niba, Toshio Saito, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 11939-11939
Open Access | Times Cited: 64
Hisahide Nishio, Emma Tabe Eko Niba, Toshio Saito, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 11939-11939
Open Access | Times Cited: 64
Spinal Muscular Atrophy Treatment in Patients Identified by Newborn Screening—A Systematic Review
Karolina Aragon‐Gawinska, Charlotte Mouraux, Tamara Dangouloff, et al.
Genes (2023) Vol. 14, Iss. 7, pp. 1377-1377
Open Access | Times Cited: 47
Karolina Aragon‐Gawinska, Charlotte Mouraux, Tamara Dangouloff, et al.
Genes (2023) Vol. 14, Iss. 7, pp. 1377-1377
Open Access | Times Cited: 47
Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020–2023)
Bradford L. Therrell, Carmencita D. Padilla, Gustavo Borrajo, et al.
International Journal of Neonatal Screening (2024) Vol. 10, Iss. 2, pp. 38-38
Open Access | Times Cited: 31
Bradford L. Therrell, Carmencita D. Padilla, Gustavo Borrajo, et al.
International Journal of Neonatal Screening (2024) Vol. 10, Iss. 2, pp. 38-38
Open Access | Times Cited: 31
Real-World Outcomes in Patients with Spinal Muscular Atrophy Treated with Onasemnogene Abeparvovec Monotherapy: Findings from the RESTORE Registry
Laurent Servais, John Day, Darryl C. De Vivo, et al.
Journal of Neuromuscular Diseases (2024) Vol. 11, Iss. 2, pp. 425-442
Open Access | Times Cited: 26
Laurent Servais, John Day, Darryl C. De Vivo, et al.
Journal of Neuromuscular Diseases (2024) Vol. 11, Iss. 2, pp. 425-442
Open Access | Times Cited: 26
Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy
Oliver Schwartz, Katharina Vill, Michelle Pfaffenlehner, et al.
JAMA Pediatrics (2024) Vol. 178, Iss. 6, pp. 540-540
Closed Access | Times Cited: 26
Oliver Schwartz, Katharina Vill, Michelle Pfaffenlehner, et al.
JAMA Pediatrics (2024) Vol. 178, Iss. 6, pp. 540-540
Closed Access | Times Cited: 26
Australian Public Perspectives on Genomic Newborn Screening: Risks, Benefits, and Preferences for Implementation
Fiona Lynch, Stephanie Best, Clara Gaff, et al.
International Journal of Neonatal Screening (2024) Vol. 10, Iss. 1, pp. 6-6
Open Access | Times Cited: 19
Fiona Lynch, Stephanie Best, Clara Gaff, et al.
International Journal of Neonatal Screening (2024) Vol. 10, Iss. 1, pp. 6-6
Open Access | Times Cited: 19
Treatment Options in Spinal Muscular Atrophy: A Pragmatic Approach for Clinicians
Sithara Ramdas, Maryam Oskoui, Laurent Servais
Drugs (2024) Vol. 84, Iss. 7, pp. 747-762
Closed Access | Times Cited: 6
Sithara Ramdas, Maryam Oskoui, Laurent Servais
Drugs (2024) Vol. 84, Iss. 7, pp. 747-762
Closed Access | Times Cited: 6
Multiplex Real-Time PCR-Based Newborn Screening for Severe Primary Immunodeficiency and Spinal Muscular Atrophy in Osaka, Japan: Our Results after 3 Years
Tomokazu Kimizu, Masatoshi Nozaki, Yousuke Okada, et al.
Genes (2024) Vol. 15, Iss. 3, pp. 314-314
Open Access | Times Cited: 5
Tomokazu Kimizu, Masatoshi Nozaki, Yousuke Okada, et al.
Genes (2024) Vol. 15, Iss. 3, pp. 314-314
Open Access | Times Cited: 5
Systematic Review of Presymptomatic Treatment for Spinal Muscular Atrophy
Katy Cooper, Gamze Nalbant, Anthea Sutton, et al.
International Journal of Neonatal Screening (2024) Vol. 10, Iss. 3, pp. 56-56
Open Access | Times Cited: 5
Katy Cooper, Gamze Nalbant, Anthea Sutton, et al.
International Journal of Neonatal Screening (2024) Vol. 10, Iss. 3, pp. 56-56
Open Access | Times Cited: 5
Cost-Effectiveness Analysis of Newborn Screening for Spinal Muscular Atrophy in Italy
Gianni Ghetti, Francesco Saverio Mennini, Andrea Marcellusi, et al.
Clinical Drug Investigation (2024) Vol. 44, Iss. 9, pp. 687-701
Open Access | Times Cited: 5
Gianni Ghetti, Francesco Saverio Mennini, Andrea Marcellusi, et al.
Clinical Drug Investigation (2024) Vol. 44, Iss. 9, pp. 687-701
Open Access | Times Cited: 5
Deciphering spinal muscular atrophy: the need for more research
Michelle A. Farrar, Didu Sanduni Kariyawasam
The Lancet Neurology (2024) Vol. 23, Iss. 2, pp. 134-136
Closed Access | Times Cited: 4
Michelle A. Farrar, Didu Sanduni Kariyawasam
The Lancet Neurology (2024) Vol. 23, Iss. 2, pp. 134-136
Closed Access | Times Cited: 4
Early spinal muscular atrophy treatment following newborn screening: A 20‐month review of the first Italian regional experience
Delia Gagliardi, Eleonora Canzio, Paola Orsini, et al.
Annals of Clinical and Translational Neurology (2024) Vol. 11, Iss. 5, pp. 1090-1096
Open Access | Times Cited: 4
Delia Gagliardi, Eleonora Canzio, Paola Orsini, et al.
Annals of Clinical and Translational Neurology (2024) Vol. 11, Iss. 5, pp. 1090-1096
Open Access | Times Cited: 4
Evaluating the performance of four assays for carrier screening of spinal muscular atrophy
Jianxin Tan, Jingjing Zhang, Ruihong Sun, et al.
Clinica Chimica Acta (2023) Vol. 548, pp. 117496-117496
Closed Access | Times Cited: 10
Jianxin Tan, Jingjing Zhang, Ruihong Sun, et al.
Clinica Chimica Acta (2023) Vol. 548, pp. 117496-117496
Closed Access | Times Cited: 10
Clinical relevance of zebrafish for gene variants testing. Proof-of-principle with SMN1/SMA.
Brett W. Stringer, Yougang Zhang, Afsaneh Taghipour Sheshdeh, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Brett W. Stringer, Yougang Zhang, Afsaneh Taghipour Sheshdeh, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
The Socio-Economic Burden of Spinal Muscular Atrophy: A Cost-of-Illness Study in Bulgaria
Elizabet Dzhambazova, Костадин Костадинов, Lilia Tsenkova-Toncheva, et al.
Healthcare (2025) Vol. 13, Iss. 4, pp. 401-401
Open Access
Elizabet Dzhambazova, Костадин Костадинов, Lilia Tsenkova-Toncheva, et al.
Healthcare (2025) Vol. 13, Iss. 4, pp. 401-401
Open Access
Views of the Public and Healthcare Professionals on Newborn Screening for Spinal Muscular Atrophy and the Potential for Detecting Adult-Onset Types in Patients-in-Waiting in Hong Kong
Chloe Miu Mak, J. K. Lee, Jimmy Chi Lap Wong, et al.
Cureus (2025)
Open Access
Chloe Miu Mak, J. K. Lee, Jimmy Chi Lap Wong, et al.
Cureus (2025)
Open Access
Pre‐symptomatic risdiplam treatment for spinal muscular atrophy initiated at 12 days post‐birth: 14‐month safety and developmental outcomes
Zhihao Sun, Liping Wu, Yufan Hui, et al.
Pediatric Investigation (2025)
Open Access
Zhihao Sun, Liping Wu, Yufan Hui, et al.
Pediatric Investigation (2025)
Open Access
Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in Australian Hospitals
Ian Woodcock, Didu Kariyawasam, Maina Kava, et al.
Neurology and Therapy (2025)
Open Access
Ian Woodcock, Didu Kariyawasam, Maina Kava, et al.
Neurology and Therapy (2025)
Open Access
An Explorative Qualitative Study of the Role of a Genetic Counsellor to Parents Receiving a Diagnosis After a Positive Newborn Bloodspot Screening
Samantha A. Sandelowsky, Alison McEwen, Jacqui Russell, et al.
International Journal of Neonatal Screening (2025) Vol. 11, Iss. 2, pp. 32-32
Open Access
Samantha A. Sandelowsky, Alison McEwen, Jacqui Russell, et al.
International Journal of Neonatal Screening (2025) Vol. 11, Iss. 2, pp. 32-32
Open Access
The Importance of Early Treatment of Inherited Neuromuscular Conditions
Laurane Mackels, Laurent Servais
Journal of Neuromuscular Diseases (2024) Vol. 11, Iss. 2, pp. 253-274
Open Access | Times Cited: 3
Laurane Mackels, Laurent Servais
Journal of Neuromuscular Diseases (2024) Vol. 11, Iss. 2, pp. 253-274
Open Access | Times Cited: 3
Clinical Perspectives: Treating Spinal Muscular Atrophy
Molly McPheron, Marcia V. Felker
Molecular Therapy (2024) Vol. 32, Iss. 8, pp. 2489-2504
Closed Access | Times Cited: 3
Molly McPheron, Marcia V. Felker
Molecular Therapy (2024) Vol. 32, Iss. 8, pp. 2489-2504
Closed Access | Times Cited: 3
Newborn screening facilitates early theranostics and improved spinal muscular atrophy outcome: five-year real-world evidence from Taiwan
Chen‐Hua Wang, Ting‐Rong Hsu, Mei‐Ying Liu, et al.
Orphanet Journal of Rare Diseases (2025) Vol. 20, Iss. 1
Open Access
Chen‐Hua Wang, Ting‐Rong Hsu, Mei‐Ying Liu, et al.
Orphanet Journal of Rare Diseases (2025) Vol. 20, Iss. 1
Open Access
The efficacy of gene therapy with onasemnogene abeparvovec in spinal muscular atrophy in young patients
Daria A. Fisenko, А. Л. Куренков, Л. М. Кузенкова, et al.
L O Badalyan Neurological Journal (2025) Vol. 6, Iss. 1, pp. 13-25
Closed Access
Daria A. Fisenko, А. Л. Куренков, Л. М. Кузенкова, et al.
L O Badalyan Neurological Journal (2025) Vol. 6, Iss. 1, pp. 13-25
Closed Access
Decision-making and challenges within the evolving treatment algorithm in spinal muscular atrophy: a clinical perspective
Lakshmi Balaji, Michelle A. Farrar, Arlene D’Silva, et al.
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 7, pp. 571-586
Closed Access | Times Cited: 8
Lakshmi Balaji, Michelle A. Farrar, Arlene D’Silva, et al.
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 7, pp. 571-586
Closed Access | Times Cited: 8
